Return to ads
All categories
Lantus

Lantus

Posted by
Posting ads for 49 years
Sanofi-Aventis says data confirms Lantus safety By Sarah TurnerLONDON (MarketWatch) -- Shares of drugmaker Sanofi-Aventis (fr:san)(sny)dropped 8.2% in Paris on Friday.

"Commentary is circulating in the market that a safety issue may soon emerge for Lantus (long-acting insulin for diabetes), a major driver of revenue growth and profits at Sanofi-Aventis," noted analysts at Credit Suisse in a note.

"However, given the lack of any details, Credit Suisse Research prefers not to make any change yet to forecasts or valuation and retains an Outperform rating on the stock," they added.

A spokesman for Sanofi-Aventis said: "data from clinical studies involving over 70,000 patients as well as data from post-marketing surveillance covering 24 million patient years of experience confirms the safely profile of Lantus."

http://www.marketwatch.com/story/sanofi-aventis-says-data-confirms-lantus-safety
Reply to this ad
Recently viewed ads
Saved ads
Please log in to browse your saved adverts or sign up if you don't have an account yet.
Popular Stuff